Carregant...
Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
PURPOSE: Intravenous (IV) zoledronic acid (ZA) is commonly used to delay skeletal complications secondary to bone metastases. However, the time associated with ZA administration may represent a significant burden to healthcare providers and patients. This study assessed the time associated with IV Z...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304336/ https://ncbi.nlm.nih.gov/pubmed/22427731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S27693 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|